Easom Eric

Chief Executive Officer

1 company

Strong

Trades Analyzed

12M Win Rate

73.7%

Avg 3M Return

+23.5%

Avg 12M Return

+6.3%

Easom Eric is a Chief Executive Officer at AN2 Therapeutics, Inc.. Recent SEC Form 4 filings include 3 buys and 19 sells.

Estimated insider holdings value: $1.2M based on current market prices.

Holdings by Company

ANTXJun 2, 2025

Current Shares256.4K

Value$1.18M

Net Activity-27,008

Bought: 70.0KSold: 97.0K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 2, 2025	ANTX An2 Therapeutics, Inc.	Chief Executive Officer	Buy	10,000	$1.07	$10,665.00	+4.1%	+8.5%	-
Nov 18, 2024	ANTX An2 Therapeutics, Inc.	Chief Executive Officer	Buy	50,000	$1.00	$49,970.00	+4.9%	+14.0%	+12.0%
Jan 2, 2024	ANTX An2 Therapeutics, Inc.	Chief Executive Officer	Sell	2,777	$20.09	$55,802.43	-56.6%	-81.1%	-93.0%
May 15, 2023	ANTX An2 Therapeutics, Inc.	Chief Executive Officer	Buy	10,000	$5.38	$53,770.00	+1.0%	+54.9%	-57.6%
Nov 14, 2022	ANTX An2 Therapeutics, Inc.	Chief Executive Officer	Sell	4,436	$15.32	$67,974.26	-31.1%	-3.6%	+8.2%
Nov 9, 2022	ANTX An2 Therapeutics, Inc.	Chief Executive Officer	Sell	17,166	$15.60	$267,793.63	-32.2%	-3.8%	-3.0%
Nov 7, 2022	ANTX An2 Therapeutics, Inc.	Chief Executive Officer	Sell	35,196	$15.86	$558,274.02	-29.5%	-8.7%	-14.2%
Nov 2, 2022	ANTX An2 Therapeutics, Inc.	Chief Executive Officer	Sell	4,232	$15.27	$64,625.20	-27.1%	-18.8%	+0.1%
Oct 28, 2022	ANTX An2 Therapeutics, Inc.	Chief Executive Officer	Sell	2,607	$15.18	$39,582.39	-18.5%	-18.3%	-3.5%
Oct 26, 2022	ANTX An2 Therapeutics, Inc.	Chief Executive Officer	Sell	9,350	$15.76	$147,357.73	-23.8%	-33.5%	-1.3%